Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 2004 Sep;11(5):952–956. doi: 10.1128/CDLI.11.5.952-956.2004

Analysis of Possible Factors Affecting the Specificity of the Gamma Interferon Test in Tuberculosis-Free Cattle Herds

M Cagiola 1,*, F Feliziani 1, G Severi 1, P Pasquali 2, D Rutili 1
PMCID: PMC515264  PMID: 15358658

Abstract

Bovine tuberculosis (TB) is still a zoonotic problem in the world. Despite the fact that eradication programs for bovine TB are being implemented in many countries, it remains a public health problem. These programs are mainly based on a single intradermal tuberculin test using bovine tuberculin purified protein derivative (PPD), isolation, and slaughtering of infected animals. The aim of this study was to assess the specificity of the gamma interferon (IFN-γ) test in TB-free cattle herds, by using not only Australian tuberculins but also tuberculins produced at our institute, and to correlate the response with the type of production (beef cattle, dairy cattle, and a dual-purpose breed), the housing system, and the age of the animals. We studied 800 animals selected from 20 TB- and paratuberculosis-free herds. The animals were tested in parallel, after stimulation with Australian tuberculins and tuberculins produced at our institute, by using the skin test and two IFN-γ assays. The results of this trial showed that the specificity of the IFN-γ test is higher than that of the skin test (96.8%) and ranges from 97.3% (using only Australian tuberculins) to 98.6% (using tuberculins produced at our institute). We found that different categories of cattle could influence the specificity of the skin test but that these differences tended to be reduced in the IFN-γ assay, especially when Italian PPDs were used.


Bovine tuberculosis (TB) is a chronic bacterial disease of animals and humans. The disease has a worldwide distribution. In many countries bovine TB is still a major infectious disease among domestic animals and the wildlife population, and transmission to humans constitutes a public health problem (13, 19). Bovine TB infection in cattle is usually diagnosed in live animals on the basis of delayed hypersensitivity reactions, elicited by intradermal inoculation of tuberculin and assessed after 72 h (32).

The specificity of clinical signs is low, and in less-advanced infections there may be no clinical signs of the disease. Eradication programs for bovine TB are being implemented in many countries; these are mainly based on the single intradermal tuberculin test using bovine tuberculin purified protein derivative (PPD). The strategy that has allowed the disease to be kept under control in Italy is based on the use of the skin test (5), isolation, and slaughtering of infected animals. The prevalence of the disease in Italy has decreased to less than 1% (2). However, to eliminate the disease, further diagnostic tests are needed, to be used in vivo together with the tuberculin skin test in order to increase sensitivity and specificity (4, 15). Indeed, in some geographical areas where the disease is becoming relatively scarce, exposure to environmental mycobacteria (such as those in bird feces and natural vehicles of infection) could induce a nonspecific reaction to the TB skin test and hinder the eradication of TB (31).

Many studies of serological assays that detect circulating antibodies to Mycobacterium bovis have been carried out. None have shown adequate sensitivity or specificity (10, 16, 17, 21, 23, 25). Their failure can be attributed to the nature of the immunological response generated in M. bovis-infected cattle: it has been shown that most infected cattle have an effective cell-mediated immune response (CMI), with minor involvement of the humoral immune response (20). CMI has been widely recognized as the main factor involved in the containment of the infection (3, 26). According to these findings, diagnosis of TB should also be based on the evaluation of CMI. A promising enzyme-linked immunosorbent assay (ELISA), which may be employed as a useful ancillary test, has been proposed lately (1). The gamma interferon (IFN-γ) test has turned out to be the best, because it measures the in vitro proliferation of stimulated T cells from M. bovis-infected animals on the basis of production of the cytokine IFN-γ (29), which is predominantly released by T cells after antigenic stimulation. IFN-γ is thought to be involved in immunity to mycobacterial infections and is released in vitro in quantities that are readily measurable by enzyme immunoassay (32). Indeed, the IFN-γ assay, as other authors have already demonstrated (15, 28, 31), has proved extremely useful as an in vitro supportive test for the skin test, because it has high sensitivity and specificity (8, 24, 30). For that reason, the IFN-γ test has been used in Northern Italy and has made a valuable contribution to the eradication of TB in cattle (2). In order to better assess the efficacy of the IFN-γ test, we carried out a trial using animals from TB-free herds, considering different parameters which could modify the test's specificity.

MATERIALS AND METHODS

Animals.

Eight hundred cows were selected from 20 officially certified TB-free herds in the Region of Umbria (Italy), into which no cows from other herds had been introduced in the previous 2 years. The animals were found to be free of paratuberculosis, as confirmed by serological tests and by the absence of clinical signs over the years. The animals were tested in parallel by use of a skin test and two IFN-γ assays, one with Australian PPDs and one with PPDs produced at our institute.

Experimental design.

All the animals involved in the trial were divided according to the type of production (beef cattle, dairy cattle, or dual-purpose breed), the housing system, and age. They were analyzed to ascertain their TB status by using the skin and IFN-γ tests as described below. The specificity of the diagnostic test was evaluated for each group.

Tuberculin skin test.

A single comparative intradermal skin test was performed by using bovine (50,000 IU/ml) and avian (25,000 IU/ml) tuberculins produced at our licensed laboratory. Italian bovine tuberculins are produced only at our authorized laboratory (Istituto Zooprofilattico Umbria e Marche) and another laboratory (Istituto Zooprofilattico Abruzzo e Molise). The avian tuberculin is produced only at our authorized laboratory. We sell the tuberculins only to Veterinary Health Units. The same Ministerial protocol for the production of tuberculins is followed at both institutes. Ministerial authorities oversee the process and ensure standardization of the products at both institutes according to the criteria reported in the manual of the Office International des Epizooties (18).

The potency of our tuberculins (50,000 IU/ml) is estimated by comparison, in previously sensitized guinea pigs, with bovine and avian PPDs prepared according to the Weybridge Reference Standard.

The skin test involves intradermal injection of the tuberculins, and the interpretation is based on observation and the recorded increase in skin thickness. In the single intradermal test (a single injection of bovine tuberculin), the animals were considered negative if only limited swelling was observed, with an increase of no more than 2 mm in skin thickness, and with no clinical signs.

The animals were considered dubious if no clinical signs were observed or if the increase in skin thickness was more than 2 mm and less than 4 mm.

The animals were considered positive if clinical signs were observed or if there was an increase of 4 mm or more in skin thickness.

Animals that were positive by the single intradermal test were subjected to the comparative intradermal test (injections of bovine and avian tuberculins).

In the interpretation of this kind of test, animals were considered to be positive if the bovine reaction was positive and more than 4 mm greater than the avian reaction. Animals were considered dubious if the bovine reaction was positive and 1 to 4 mm greater than the avian reaction.

The animals were considered negative if the bovine reaction was negative or if the bovine reaction was positive but equal to or less than a positive avian reaction. Animals that tested bovine tuberculin positive by the single intradermal test, dubious by the comparative intradermal test, and negative by tests carried out after slaughtering were considered false positive.

IFN-γ test.

A heparinized blood sample (10 ml) was collected from each animal just before the tuberculin skin test was carried out. The samples were delivered to the lab within 8 to 10 h of blood collection. Each sample (1.5 ml) was divided into several aliquots, and each aliquot was stimulated, not only with 30 μg of Australian bovine PPD and 30 μg of Australian avian PPD (CSL Ltd., Melbourne, Australia), as suggested in the manual for the Bovigam ELISA (CSL Ltd.), but also with 10 μg of bovine PPD and 10 μg of avian PPD produced at our institute by the method described previously (8, 12). The concentrations of the Australian and Italian tuberculins were determined on the basis of the results obtained by trials described previously (11, 25).

Italian researchers have demonstrated that good IFN-γ production is obtained, in blood samples of skin test-positive animals, by using a low concentration (10 μg/ml) of Italian PPDs.

A solution of phosphate-buffered saline (PBS) (0.01 M; pH 7.2) was used to estimate the basal value of IFN-γ. Blood samples were incubated at 37°C in a humidified atmosphere (5% CO2) for 16 to 24 h. After incubation, the plasma of each sample was collected by centrifuging the blood cultures at 500 × g for 10 min at room temperature (22 ± 5°C); this plasma was tested with the Bovigam ELISA (CSL Ltd.) by following the instructions included in the kit. The optical density (OD) of the results was measured with a spectrophotometer (450 nm). Because the basal OD of the animals tested in Italy was higher than 0.05 (7), in order to obtain a superior cutoff (29), we have modified the Australian method of identifying bovine TB-positive animals (B > N + 0.05 and B ≥ A, where B is M. bovis positive, N is negative, 0.05 is the cutoff OD, and A is Mycobacterium avium positive) according to the following criteria described by other authors (6, 7, 11). (i) Samples were considered unfit if the basal OD was higher than 0.150. (ii) Samples were considered negative when the ODs of samples stimulated with avian PPD and bovine PPD were less than twice the OD obtained for PBS-stimulated (negative) cells. (iii) Samples were considered M. bovis positive when the ODs of samples stimulated with bovine PPD were more than or equal to twice the OD obtained for PBS-stimulated cells and the ODs of samples stimulated with avian PPD were less than twice the OD of PBS-stimulated cells. (iv) Samples were considered M. avium positive when the ODs of samples stimulated with avian PPD were more than or equal to twice the OD obtained for PBS-stimulated cells and the ODs of samples stimulated with bovine PPD were less than twice the OD of PBS-stimulated cells. (v) Samples were considered M. bovis positive when the ODs of samples stimulated with bovine PPD and samples stimulated with avian PPD were both more than twice the OD obtained for PBS-stimulated cells, and the ratio between the ODs of bovine PPD- and avian PPD-stimulated cells was higher than 1.1. (vi) Samples were considered M. avium positive when the ODs of samples stimulated with avian PPD and samples stimulated with bovine PPD were both more than twice the OD obtained for PBS-stimulated cells, and the ratio between the ODs of bovine PPD- and avian PPD-stimulated cells was less than 0.9. (vii) The reaction was considered unresolved when the ODs of samples stimulated with bovine PPD and samples stimulated with avian PPD were both more than twice the OD obtained for PBS-stimulated cells and the ratio between the ODs of bovine PPD- and avian PPD-stimulated cells was in the 0.9-to-1.1 range.

Animals testing positive for bovine TB by the IFN-γ test but negative by the tests carried out after slaughtering were considered false positive.

Statistical analysis.

Specificity was measured as the percentage of negative results in the total population and was calculated by the following formula: true negatives × 100/(true negatives + false positives). The confidence limits (LC) were calculated by using the normal distribution for infinite populations. The confidence level was considered to be 95% (27). The statistical significances of several differences found in the analysis and the grouping of data were also calculated. EPI INFO 2000, freeware distributed by the Centers for Disease Control and Prevention, Atlanta, Ga., was used as an electronic support for statistical calculations.

RESULTS

Results of the skin test and the two IFN-γ assays.

Out of 800 animals tested, 25 tested positive by the single intradermal test, 21 were found reactive to M. bovis by the IFN-γ assay using Australian PPDs, and 11 were found reactive to M. bovis by the IFN-γ assay using PPDs produced at our institute. The animals that were found to be M. bovis reactors in the IFN-γ assays were the same as those that were positive by the skin test.

Animals with positive results by these tests were slaughtered, and we carried out a postmortem examination and classical microbiological isolation, performed on their mediastinic and retropharyngeal lymph nodes. All the slaughtered animals tested negative by the postmortem exams and were considered false-positive animals (Table 1). We compared the results obtained by using different tuberculins in the IFN-γ assay, and then we compared these results with those obtained by the skin test. Statistical analysis showed that in the IFN-γ assay, the use of Australian PPDs or PPDs produced at our institute did not give statistically different results (P = 0.108; χ2 = 2.58), but the difference between the IFN-γ assay using PPDs produced at our institute and the skin test was significant (P = 0.02; χ2 = 4.80), while the difference between the IFN-γ assay using Australian PPDs and the skin test was not significant (P = 0.65 χ2 = 0.20) (a P value of ≤0.05 was considered significant).

TABLE 1.

Results of the skin test and IFN-γ assays

Testa No. of animals testing
Specificity (LC; CI)c
M. bovis negative M. bovis false positiveb
Skin test 775 25 a 96.8 (95; 35-97.93)
IFN-γ assay
    With Australian antigen 779 21 ab 97.34 (95; 95.9-98.3)
    With Italian antigen 789 11 b 98.6 (95; 97.5-99.3)
a

A total of 800 animals were tested.

b

Categories were compared; values with different letters are statistically different from each other (P ≤ 0.05).

c

Specificity, LC, and CI are expressed as percentages.

Results classified by the different categories of animals.

In order to assess whether different categories of animals respond differently to the diagnostic tests, we divided the tested animals according to the type of production (beef cattle, dairy cattle, or dual-purpose breed), the housing system, and age.

Type of production.

The results of the IFN-γ assay demonstrated that fattening farms, containing only beef cattle, showed fewer reactors to M. bovis than breeding farms containing dairy cattle (Table 2). These differences were confirmed by the P values (P < 0.0005) of the χ2 test using 2 degrees of freedom. The use of Italian or Australian PPDs showed similar trends, although PPDs produced at our institute showed fewer reactors in all categories. According to the results of the skin test, it is possible to estimate that animals raised for beef production are three times less likely to show false-positive reactions than animals sampled in farms containing dairy cattle (odds ratio, 3.30; 95% confidence interval [95% CI], 1.50 to 7.24; LC, 95% [P < 0.005]).

TABLE 2.

Results of IFN-γ assays according to the type of production

Production type No. of animals tested No. of animals with the indicated result by the following test:
Skin test
IFN-γ assay
With Australian antigen
With Italian antigen
Negative M. bovis false positivea Negative M. bovis false positivea M. avium positive Negative M. bovis false positivea M. avium positive
Beef 550 540 10 a 541 4 a 5 529 3 a 18
Dual purpose 150 145 5 ab 124 8 b 18 127 5 b 18
Dairy 100 90 10 b 70 9 b 21 69 3 b 28
a

Categories were compared; values with different letters are statistically different from each other (P ≤ 0.05).

Housing system.

Another parameter utilized to evaluate different specificities was the housing system (Table 3). When results were clustered by the type of housing system, we found that with the IFN-γ assay, the tie stall system of housing showed fewer animals falsely positive to M. bovis, while more animals reared in a free-housing system or under mixed conditions reacted positively to M. bovis, especially when both our PPDs and Australian PPDs were used (P < 0.05 by the χ2 test using 2 degrees of freedom).

TABLE 3.

Results of the IFN-γ assays according to the housing system

Housing system category No. of animals tested No. of animals with the indicated result by the following test:
Skin test
IFN-γ assay
With Australian antigen
With Italian antigen
Negative M. bovis false positivea Negative M. bovis false positivea M. avium positive Negative M. bovis false positivea M. avium positive
Tie stall 350 345 5 a 349 0 a 1 349 0 a 1
Mixed housing 300 290 10 ab 270 10 b 20 267 5 b 28
Free housing 150 140 10 b 116 11 b 23 109 6 b 35
a

Categories were compared; numbers with different letters are statistically different (P ≤ 0.05)

According to the results of the skin test, the risk of animals reacting positively to M. bovis was three times higher with a free- or mixed-housing system than with a tie stall system (odds ratio, 3.11; 95% CI, 1.18 to 8.21; LC, 95% [P < 0.005]).

Age.

We divided the animals into three groups according to age. When the animals were analyzed by the skin test, the statistical analysis clearly showed that animals in the 2- to 3-year age group had the highest reactivity relative to animals in the 4- to 5-year and 6- to 7-year age group (Table 4). This information was not confirmed when we used the IFN-γ assay. There were no statistically significant differences (P > 0.05 by the χ2 test using 2 degrees of freedom).

TABLE 4.

Results of IFN-γ assays according to age

Age (yr) No. of animals tested No. of animals with the indicated result by the following test:
Skin test
IFN-γ assay
With Australian antigen
With Italian antigen
Negative M. bovis false positivea Negative M. bovis false positivea M. avium positive Negative M. bovis false positivea M. avium positive
2-3 150 142 8 ab 140 4 a 6 140 1 a 9
4-5 500 483 17 a 471 15 a 14 466 9 a 25
6-7 150 150 0 b 124 2 a 24 119 1 a 30
a

Categories were compared; numbers with different letters are statistically different (P ≤ 0.05).

DISCUSSION

The aim of the present study was to evaluate the specificity of the diagnostic tests used in the TB eradication programs. Our findings showed that the IFN-γ assay has a higher specificity than the skin test in TB-free herds. In fact, specificities were 96.8% with the skin test, 97.3% with the IFN-γ assay using Australian PPDs, and 98.6% with the IFN-γ assay using PPDs produced at our institute; these values are higher than those reported by other authors (6). It is noteworthy that the Italian tuberculins had a lower concentration of PPD than the Australian tuberculins while achieving comparable results. This suggests that the biological effect of PPD does not depend on its protein content. The use of tuberculins produced at our authorized institute in the IFN-γ assay has also permitted a reduction in the number of false-positive animals (from 21 to 11), highlighting the presence of a higher number of M. avium reactors (Tables 2, 3, and 4). The above data revealed that different parameters can influence the test results. The IFN-γ assay tends to reduce these influences, especially when our PPDs are used to stimulate blood lymphocytes. We found that the number of M. bovis reactors was different when the animals were assayed with the skin test versus the IFN-γ assay. The skin test specificities recorded were lower than the specificities of the IFN-γ assay using PPD produced at our institute, as confirmed by the χ2 test. These results strongly suggest that a possible way to improve diagnostic procedures, in order to better control the spread of TB, might be based on the right choice of diagnostic test, focusing particular attention on the characteristics of the PPDs. Field trials have been conducted in different countries, and the results obtained suggest that the IFN-γ assay is more specific than the skin test (32). We found that the housing system and the type of production could influence the specificity of the TB diagnostic tests. Even though our results do not throw light on the reason for this, we can suppose that these effects result from exposure to environmental mycobacteria, which can sensitize the animals. Indeed, other authors (9, 14, 15, 22) have advanced the hypothesis that the contamination of feed with environmental mycobacteria, present in bird feces, and possible contact with other natural vehicles of infection, could induce a nonspecific reaction in the TB skin test. With regard to age, we noted that the risk of sensitization is higher for cows 2 to 3 and 4 to 5 years old than for cows 6 to 7 years old.

The reason for this, as other authors have reported (15), is the complex antigenic structure of bovine tuberculin, some particular components of which could induce an immunosuppressive response after repeated intradermal injections. This hypothesis has also been suggested by authors who found a similar phenomenon when using tuberculin on humans (3). On the basis of the results obtained from our research, especially regarding the high level of specificity (98.6%) achieved with the IFN-γ test using the tuberculin produced at our institute, we can conclude that the IFN-γ assay would be a valid diagnostic aid, together with the skin test, in the final phases of eradication programs.

Acknowledgments

We thank the Local Veterinary Health Units of the Region of Umbria for support in collecting blood samples and tuberculin testing.

We acknowledge Sabrina Monaco for the English language revision.

REFERENCES

  • 1.Amadori, M., K. P. Lyashchenko, M. L. Gennaro, J. M. Pollock, and I. Zerbini. 2002. Use of recombinant proteins in antibody tests for bovine tuberculosis. Vet. Microbiol. 85:379-389. [First published 30 January 2002; 10.1016/S0378-1135(02)00005-6.] [DOI] [PubMed] [Google Scholar]
  • 2.Archetti, I. L., M. Amadori, P. Scaccaglia, F. Vezzoli, M. Luini, M. Fabbi, A. Belloli, and L. Sala. 1996. Impiego del test γ-interferon per la diagnosi di tubercolosi bovina in regione Lombardia. Selez. Vet. 4:329-338. [Google Scholar]
  • 3.Bernstein, E., D. Kaye, E. Abrutyn, P. Gross, M. Dorfman, and D. M. Murasko. 1999. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 17:82-94. [DOI] [PubMed] [Google Scholar]
  • 4.Buddle, B. M., T. J. Ryan, J. M. Pollock, P. Andersen, and G. W. De Lisle. 2001. Use of ESAT-6 in the interferon-γ test for diagnosis of bovine tuberculosis following skin testing. Vet. Microbiol. 80:37-46. [First published 22 March 2001; 10.1016/S0378-1135(00)00375-8.] [DOI] [PubMed] [Google Scholar]
  • 5.Caffrey, J. P. 1994. Status of bovine tuberculosis eradication programmes in Europe. Vet. Microbiol. 40:1-4. [DOI] [PubMed] [Google Scholar]
  • 6.Dondo, A., M. Goria, G. Moda, L. Cesano, A. Garanzini, M. Giammartino, G. Minola, E. Moriconi, G. Porta, P. Banchio, and G. Marmo. 1996. La prova del γ-interferone per la diagnosi della tubercolosi bovina: determinazione della sensibilità e della specificità in prove di campo. Med. Vet. Prevent. 13:14-18. [Google Scholar]
  • 7.Dondo, A., and M. Goria. 1997. Diagnosi in vita della tubercolosi bovina mediante γ-interferon test, 74-82. In Infezioni da micobatteri tubercolari e non tubercolari negli animali e nell'uomo: attualità e prospettive future. Atti del Congresso. Veterinary Association of Cuneo, Fossano-Cuneo, Italy.
  • 8.Dondo, A., and M. Goria. 1998. Esperienze nell'impiego della prova del gamma interferone. Med. Vet. Prevent. 1998(Suppl.):41-46. [Google Scholar]
  • 9.Donoghue, H. D., E. Overend, and J. L. Stanford. 1997. A longitudinal study of environmental mycobacteria on a farm in south-west England. J. Appl. Microbiol. 82:56-67. [DOI] [PubMed] [Google Scholar]
  • 10.Fifis, T., C. Costopoulos, L. A. Corner, and P. R. Wood. 1992. Serological reactivity to Mycobacterium bovis protein antigen in cattle. Vet. Microbiol. 30:343-354. [DOI] [PubMed] [Google Scholar]
  • 11.Goria, M., L. Faccenda, C. Bianco, P. Gemello, E. Pizzoni, and A. Dondo. 1997. Impiego del γ-IFN test nella diagnosi di tubercolosi bovina in allevamenti infetti da M. paratuberculosis. Prog. Vet. 11:399-401. [Google Scholar]
  • 12.Goria, M., A. Dondo, M. Amadori., E. Lodetti, G. Bellan, and L. Nicolandi. 1993. Diagnosis of bovine tuberculosis: in vitro stimulation of cell-mediated immune response by different preparations of PPD tuberculin. Atti Soc. Ital. Sci. Vet. 1993:917-921. [Google Scholar]
  • 13.Grange, J. M. 2001. Mycobacterium bovis infection in human beings. Tuberculosis 81:71-77. [DOI] [PubMed] [Google Scholar]
  • 14.Ichiyama, S., K. Shimokata, and M. Tsukamura. 1988. The isolation of Mycobacterium avium complex from soil, water and dusts. Microbiol. Immunol. 32:733-739. [DOI] [PubMed] [Google Scholar]
  • 15.Lauzi, S., D. Pasotto, M. Amadori, I. L. Archetti, G. Poli, and L. Bonizzi. 2000. Evaluation of the specificity of the γ-interferon test in Italian bovine tuberculosis-free herds. Vet. J. 160:17-24. [Online.] [DOI] [PubMed] [Google Scholar]
  • 16.Liebana, E., R. M. Girvin, M. Welsh, S. D. Neill, and J. M. Pollock. 1999. Generation of CD8+ T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis. Infect. Immun. 67:1034-1044. [Online.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lightbody, K. A., R. A. Skuce, S. D. Neil, and J. M. Pollock. 1998. Mycobacterial antigen-specific antibody responses in bovine tuberculosis: an ELISA with potential to confirm disease status. Vet. Rec. 142:295-300. [DOI] [PubMed] [Google Scholar]
  • 18.Office International des Epizooties. 2000. Manual of standards: diagnostic tests and vaccines, 4th ed., 2000. [Online.] Office International des Epizooties, Paris, France. http://www.oie.int/eng/normes/mmanual/a_00050.htm.
  • 19.O'Reilly, L. M., and C. J. Daborn. 1995. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber. Lung Dis. 76(Suppl. 1):1-46. [DOI] [PubMed] [Google Scholar]
  • 20.Plackett, P., J. Ripper, L. A. Corner, K. Small, K. de Wittle, L. Melville, S. Hides, and P. R. Wood. 1989. An ELISA for detection of anergic tuberculous cattle. Aust. Vet. J. 66:15-19. [DOI] [PubMed] [Google Scholar]
  • 21.Pollock, J. M., J. McNair, M. D. Welsh, R. M. Girvin, H. E. Kennedy, D. P. Mackie, and S. D. Neil. 2001. Immune response in bovine tuberculosis. Tuberculosis 81:103-107. [DOI] [PubMed] [Google Scholar]
  • 22.Prosser, B. A. 1989. Methods used to investigate a possible environmental source of Mycobacterium avium-intracellulare-scrofulaceum (MAIS) infection in farmed deer. J. Appl. Bacteriol. 66:219-226. [DOI] [PubMed] [Google Scholar]
  • 23.Rhodes, S. G., D. Gavier-Widen, B. M. Buddle, A. O. Whelan, M. Singh, R. G. Hewinson, and H. M. Vordermeier. 2000. Antigen specificity in experimental bovine tuberculosis. Infect. Immun. 68:2573-2578. [Online.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Rothel, J. S., S. L. Jones, L. A. Corner, J. C. Cox, and P. R. Wood. 1992. The gamma-interferon assay for diagnosis of bovine tuberculosis in cattle: conditions affecting the production of gamma-interferon in whole blood culture. Aust. Vet. J. 69:1-4. [DOI] [PubMed] [Google Scholar]
  • 25.Skinner, M. A., N. Parlane, A. McCarthy, and B. M. Buddle. 2003. Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis. Immunology 110:234-241. (10.1046/j.1365-2567.2003.01731.x.) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Thoms, C. J., and J. A. Morris. 1986. The immune spectrum of Mycobacterium bovis infections in mammmalian species; a review. Vet. Bull. Weybridge 53:543-550. [Google Scholar]
  • 27.Thrusfield, M. 1995. Veterinary epidemiology, 2nd ed., p. 199-219, 266-284. Blackwell Science Ltd., Oxford, United Kingdom.
  • 28.Whipple, D. L., C. A. Bolin, A. J. Davis, J. L. Jarnagin, D. C. Johnson, R. S. Nabors, J. B. Payeur, D. A. Saari, A. J. Wilson, and M. M. Wolf. 1995. Comparison of sensitivity of the caudal fold skin test and commercial gamma-interferon assay for diagnosis of bovine tuberculosis. Am. J. Vet. Res. 56:415-419. [PubMed] [Google Scholar]
  • 29.Wood, P. R., L. A. Corner, and P. Plackett. 1990. Development of a simple, rapid in vitro cellular assay for bovine tuberculosis based on the production of γ-interferon. Res. Vet. Sci. 49:46-49. [PubMed] [Google Scholar]
  • 30.Wood, P. R., L. A. Corner, J. S. Rothel, C. Baldock, S. L. Jones, D. B. Cousins, B. S. McCormick, B. R. Francis, J. Creeper, and N. F. Tweddle. 1991. Field comparison of the interferon-gamma assay and intradermal tuberculin test for the diagnosis of bovine tuberculosis. Aust. Vet. J. 68:286-290. [DOI] [PubMed] [Google Scholar]
  • 31.Wood, P. R., and J. Rothel. 1994. In vitro immunodiagnostic assays for bovine tuberculosis. Vet. Microbiol. 40:125-135. [DOI] [PubMed] [Google Scholar]
  • 32.Wood, P. R., and S. L. Jones. 2001. BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis. Tuberculosis 8:147-155. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES